Incannex Healthcare Ltd

STU:IQI (Australia)  
€ 0.03 (0%) Nov 29
2.01
P/B:
2.87
Market Cap:
€ 39.35M ($ 42.72M)
Enterprise V:
€ 19.65M ($ 21.33M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Incannex Healthcare Ltd ( ) from 2011 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Incannex Healthcare stock (STU:IQI) PE ratio as of May 21 2024 is 2.01. More Details

Incannex Healthcare Ltd (STU:IQI) PE Ratio (TTM) Chart

To

Incannex Healthcare Ltd (STU:IQI) PE Ratio (TTM) Historical Data

Total 1135
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 13
Incannex Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-21 At Loss 2023-09-26 At Loss
2023-11-29 At Loss 2023-09-25 At Loss
2023-11-28 At Loss 2023-09-22 At Loss
2023-11-27 At Loss 2023-09-21 At Loss
2023-11-24 At Loss 2023-09-20 At Loss
2023-11-23 At Loss 2023-09-19 At Loss
2023-11-22 At Loss 2023-09-18 At Loss
2023-11-21 At Loss 2023-09-15 At Loss
2023-11-20 At Loss 2023-09-14 At Loss
2023-11-17 At Loss 2023-09-13 At Loss
2023-11-16 At Loss 2023-09-12 At Loss
2023-11-15 At Loss 2023-09-11 At Loss
2023-11-14 At Loss 2023-09-08 At Loss
2023-11-10 At Loss 2023-09-07 At Loss
2023-11-09 At Loss 2023-09-06 At Loss
2023-11-08 At Loss 2023-09-05 At Loss
2023-11-07 At Loss 2023-09-04 At Loss
2023-11-06 At Loss 2023-09-01 At Loss
2023-11-03 At Loss 2023-08-31 At Loss
2023-11-02 At Loss 2023-08-30 At Loss
2023-11-01 At Loss 2023-08-29 At Loss
2023-10-30 At Loss 2023-08-28 At Loss
2023-10-27 At Loss 2023-08-25 At Loss
2023-10-26 At Loss 2023-08-24 At Loss
2023-10-25 At Loss 2023-08-23 At Loss
2023-10-24 At Loss 2023-08-22 At Loss
2023-10-23 At Loss 2023-08-21 At Loss
2023-10-20 At Loss 2023-08-18 At Loss
2023-10-19 At Loss 2023-08-17 At Loss
2023-10-18 At Loss 2023-08-16 At Loss
2023-10-17 At Loss 2023-08-15 At Loss
2023-10-16 At Loss 2023-08-14 At Loss
2023-10-13 At Loss 2023-08-11 At Loss
2023-10-12 At Loss 2023-08-10 At Loss
2023-10-11 At Loss 2023-08-09 At Loss
2023-10-10 At Loss 2023-08-08 At Loss
2023-10-09 At Loss 2023-08-07 At Loss
2023-10-06 At Loss 2023-08-04 At Loss
2023-10-05 At Loss 2023-08-03 At Loss
2023-10-04 At Loss 2023-08-02 At Loss
2023-10-03 At Loss 2023-08-01 At Loss
2023-10-02 At Loss 2023-07-31 At Loss
2023-09-29 At Loss 2023-07-28 At Loss
2023-09-28 At Loss 2023-07-27 At Loss
2023-09-27 At Loss 2023-07-26 At Loss

Incannex Healthcare Ltd (STU:IQI) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.